Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Retatrutide shows potential for greater efficacy through triple-agonism but awaits Phase 3 results Best For Recommendations# Currently Available Treatment# Recommendation : Tirzepatide Reason : FDA-approved and commercially available as Mounjaro/Zepbound with established dosing protocols and post-market safety data Maximum Weight Loss Potential# Recommendation : Retatrutide Reason : Phase 2 data showed 24.2% weight loss at 48 weeks, exceeding tirzepatide's results, though Phase 3 confirmation is pending Non-Alcoholic Fatty Liver Disease# Recommendation : Retatrutide Reason : Glucagon receptor agonism directly promotes hepatic fat oxidation, showing up to 82% liver fat reduction in trials Type 2 Diabetes Management# Recommendation : Tirzepatide Reason : Proven HbA1c reduction with FDA approval specifically for glycemic control in type 2 diabetes Further Reading# Which Is Better For
Why the mod GRF / CJC-1295 / sermorelin blends are searched so often
Consult your healthcare provider before use, especially if pregnant, nursing, or taking medication
By week four at 2mg, I had dropped about 9 pounds
Heres how things compare for average weight loss studies for retatrutide and tirzepatide: Around 3 months: Retatrutide: Not reported Tirzepatide: 8% Around 6 months: 1 year and beyond: Looking at these timelines, you can see that progress doesnt happen all at once
US$ 23.05
US$ 27.56
US$ 24.37
US$ 27.14
US$ 20.87
US$ 20.93
US$ 27.63
